| Cite this article: |
| WANG Weijian,LIU Fei,NIU Chong,XIE Jizhen,ZHU Qingfen,HU Defu.Research advances on drug impurity control and safety evaluation[J].Journal Of Pharmaceutical Research,2016,35(11):657-662[Click to copy] |
|
| 摘要: |
| 杂质作为影响药品安全有效性的关键因素,一直是药品质量研究、安全性评价的重点。本文围绕药品杂质控制与杂质的安全性评价两个方面,对杂质谱研究、杂质毒理学评价、杂质对照品制备等热点领域的研究现状进行了综述。 |
| 关键词: 杂质谱 基因毒性 对照品 |
| DOI:10.13506/j.cnki.jpr.2016.11.010 |
| 基金项目:国家科技重大专项课题-重大新药创制(No.2009ZX09313-023) |
|
|
|
| Research advances on drug impurity control and safety evaluation |
| WANG Weijian1,LIU Fei2,NIU Chong1,XIE Jizhen2,ZHU Qingfen1,HU Defu1 |
| (1.Shandong Institute for Food and Drug Control,Jinan 250101,China; 2.Shandong Center for Drug Evaluation and Certification,Jinan 250014,China) |
| Abstract: |
| As a key factor affecting the safety and effectiveness of drugs, impurity has always been the focus of drug quality research and safety evaluation. This paper focused on the two aspects of drug impurity control and safety evaluation, and summarized the research status of impurity profile,impurity toxicology evaluation,impurity reference substance preparation and so on. |
| Key words: Impurity profile Toxicology evaluation Reference substance |